Matej Sova

2.9k total citations · 2 hit papers
53 papers, 2.3k citations indexed

About

Matej Sova is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Matej Sova has authored 53 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Organic Chemistry and 8 papers in Pharmacology. Recurrent topics in Matej Sova's work include Genomics, phytochemicals, and oxidative stress (6 papers), Immune Response and Inflammation (6 papers) and Antimicrobial Peptides and Activities (5 papers). Matej Sova is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (6 papers), Immune Response and Inflammation (6 papers) and Antimicrobial Peptides and Activities (5 papers). Matej Sova collaborates with scholars based in Slovenia, France and Italy. Matej Sova's co-authors include Stanislav Gobec, Luciano Saso, Andreja Kovač, Didier Blanot, Hélène Barreteau, Audrey Boniface, Marko Jukič, Samo Turk, Sevdan Yılmaz and Sebahattin Ergün and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Organic Chemistry and FEMS Microbiology Reviews.

In The Last Decade

Matej Sova

53 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytoplasmic steps of peptidoglycan biosynthesis

2008 545 citations Hélène Barreteau, Andreja Kovač et al. FEMS Microbiology Reviews profile →
Antioxidant and Antimicrobial Activities of Cinnamic Acid Derivatives

2012 449 citations Matej Sova Mini-Reviews in Medicinal Chemistry profile →

Peers

Countries citing papers authored by Matej Sova

Since Specialization

Citations

This map shows the geographic impact of Matej Sova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matej Sova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matej Sova more than expected).

Fields of papers citing papers by Matej Sova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matej Sova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matej Sova. The network helps show where Matej Sova may publish in the future.

Co-authorship network of co-authors of Matej Sova

This figure shows the co-authorship network connecting the top 25 collaborators of Matej Sova. A scholar is included among the top collaborators of Matej Sova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matej Sova. Matej Sova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting TAK1: Evolution of inhibitors, challenges, and future directions 2025 ·Pharmacology & Therapeutics ·(unknown), (unknown), Christian Steinebach, Matej Sova, Izidor Sosič	2
2	Optimization of 6-(trifluoromethyl)pyrimidine derivatives as TLR8 antagonists 2025 ·Acta Pharmaceutica ·(unknown), (unknown), (unknown), (unknown), Izidor Sosič, Günther Weindl, Gerhard Wolber, Matej Sova	1
3	Discovery of Novel Isoxazole-Based Small-Molecule Toll-Like Receptor 8 Antagonists 2025 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), (unknown), Matej Sova, Gerhard Wolber, Günther Weindl	4
4	Structural Optimization and Biological Evaluation of Isoxazolo[5,4-d]pyrimidines as Selective Toll-Like Receptor 7 Agonists 2024 ·ACS Omega ·(unknown), (unknown), Urban Švajger, Izidor Sosič, Stanislav Gobec, Matej Sova	2
5	Substituted cinnamides: Characterization of non-toxic inhibitors of alpha-synuclein aggregation 2023 ·Mendeleev Communications ·(unknown), Viktor S. Stroylov, (unknown), Matej Sova, (unknown), Vladimir I. Muronetz, (unknown)	2
6	Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications 2023 ·Antioxidants and Redox Signaling ·Marialucia Gallorini, Simone Carradori, Emiliano Panieri, Matej Sova, Luciano Saso	18
7	Further hit optimization of 6-(trifluoromethyl)pyrimidin-2-amine based TLR8 modulators: Synthesis, biological evaluation and structure–activity relationships 2021 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), (unknown), Urban Švajger, Stanislav Gobec, (unknown), Günther Weindl, Gerhard Wolber, Matej Sova	5
8	Indoleamine and tryptophan 2,3-dioxygenases as important future therapeutic targets 2020 ·Pharmacology & Therapeutics ·(unknown), Stanislav Gobec, Matej Sova	55
9	Selective Toll-like receptor 7 agonists with novel chromeno[3,4-d]imidazol-4(1H)-one and 2-(trifluoromethyl)quinoline/ quinazoline-4-amine scaffolds 2019 ·European Journal of Medicinal Chemistry ·(unknown), Urban Švajger, Samo Lešnik, Janez Konc, Stanislav Gobec, Matej Sova	17
10	Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a review 2018 ·Drug Design Development and Therapy ·Matej Sova, Luciano Saso	78
11	Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities 2018 ·European Journal of Medicinal Chemistry ·Damijan Knez, Nicolas Coquelle, Anja Pišlar, Simon Žakelj, Marko Jukič, Matej Sova, Janez Mravljak, Florian Nachon, Xavier Brazzolotto, Janko Kos, Jacques‐Philippe Colletier, Stanislav Gobec	79
12	Cinnamic Acid Derivatives Induce Cell Cycle Arrest in Carcinoma Cell Lines 2013 ·Medicinal Chemistry ·Matej Sova, Željko Žižak, Jelena Antić‐Stanković, (unknown), Samo Turk, Zorica D. Juranić, Irena Mlinarič‐Raščan, Stanislav Gobec	25
13	Novel toll-like receptor 4 (TLR4) antagonists identified by structure- and ligand-based virtual screening 2013 ·European Journal of Medicinal Chemistry ·Urban Švajger, Boris Brus, Samo Turk, Matej Sova, Vesna Hodnik, Gregor Anderluh, Stanislav Gobec	39
14	Antioxidant and Antimicrobial Activities of Cinnamic Acid Derivatives breakdown → 2012 ·Mini-Reviews in Medicinal Chemistry ·Matej Sova	449
15	Design and synthesis of new hydroxyethylamines as inhibitors of d-alanyl-d-lactate ligase (VanA) and d-alanyl-d-alanine ligase (DdlB) 2009 ·Bioorganic & Medicinal Chemistry Letters ·Matej Sova, (unknown), Samo Turk, (unknown), Slovenko Polanc, Sarah Batson, Adrian J. Lloyd, David I. Roper, Colin W. G. Fishwick, Stanislav Gobec	33
16	Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF 2009 ·Bioorganic Chemistry ·Matej Sova, Andreja Kovač, Samo Turk, Martina Hrast, Didier Blanot, Stanislav Gobec	39
17	Cytoplasmic steps of peptidoglycan biosynthesis breakdown → 2008 ·FEMS Microbiology Reviews ·Hélène Barreteau, Andreja Kovač, Audrey Boniface, Matej Sova, Stanislav Gobec, Didier Blanot	545
18	Flavonoids and cinnamic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 1 2008 ·Molecular and Cellular Endocrinology ·Petra Brožič, Petra Kocbek, Matej Sova, Julijana Kristl, Stefan Martens, Jerzy Adamski, Stanislav Gobec, Tea Lanišnik Rižner	48
19	Novel inhibitors of β-ketoacyl-ACP reductase from Escherichia coli 2008 ·Chemico-Biological Interactions ·Katja Kristan, Tomaž Bratkovič, Matej Sova, Stanislav Gobec, (unknown), U. Urleb	13
20	Flavonoids and cinnamic acid esters as inhibitors of fungal 17β-hydroxysteroid dehydrogenase: A synthesis, QSAR and modelling study 2006 ·Bioorganic & Medicinal Chemistry ·Matej Sova, Andrej Perdih, Miha Kotnik, Katja Kristan, Tea Lanišnik Rižner, Tom Šolmajer, Stanislav Gobec	39

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact